Delivery Order SPE2DR25D1004-SPE2DR26FSVS0
Award Date 11/28/25
Potential Completion Date 12/1/25
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,618.42 to AmerisourceBergen Drug Corp for MYFEMBREE pharmaceutical products (40 mg, 1 mg, and 0.5 mg tablets, 28-count supply). This firm fixed-price delivery order, issued on November 24, 2025, represents a non-competitive set-aside award and is due for completion by November 25, 2025. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $1,899.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MYFEMBREE pharmaceutical products (40 mg, 1 mg, and 0.5 mg tablets, 28-count package) with a completion date of December 11, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The delivery will be performed at...
- The Defense Logistics Agency (DLA) awarded a $4,543.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MYFEMBREE pharmaceutical products (40 mg, 1 mg, and 0.5 mg tablets in a 28-count package) on October 30, 2025, with an ultimate completion date of October 31, 2025. The contract was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $2,866.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for MYFEMBREE 40 MG-1 MG-0.5 MG tablets (28-count package) on December 12, 2025, with completion scheduled for December 15, 2025. This non-set-aside contract represents a standard pharmaceutical supply transaction under the company's larger federal contracting relationship with DLA. The product will be performed and delivered from AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.13 to AmerisourceBergen Drug Corp for MYFEMBREE 40 MG-1 MG-0.5 MG tablets (28-count), a pharmaceutical product to be delivered to the company's facility in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a non-competitive award under an existing contract vehicle. The award reflects routine pharmaceutical supply procurement...
- The Defense Logistics Agency awarded a $2,233.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MYFEMBREE 40 MG-1 MG-0.5 MG tablets (28-count) with an ultimate completion date of June 2, 2025. This non-set-aside award was made competitively and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,674.10 firm-fixed-price delivery order (SPE2DB20D2104|SPE2DB24FT99S) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military...
- The Defense Logistics Agency awarded a delivery order valued at $8,499.46 to AmerisourceBergen Drug Corp for the supply of Myfembree (40 mg, 1 mg, 0.5 mg tablets, 28-count package) on April 25, 2025, with an ultimate completion date of April 28, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,547.13, is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,002.97, is a delivery order with a firm fixed price. It covers the provision of MYFEMBREE 40 MG-1 MG-0.5 MG tablets, with an ultimate completion date of November 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...